乱用薬物検査市場規模、シェア、成長分析、製品タイプ別、サンプルタイプ別、用途別、エンドユーザー別、地域別 - 産業予測、2025-2032年

乱用薬物検査の世界市場規模は2023年に38億米ドルと評価され、2024年の40億2,000万米ドルから2032年には63億1,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは5.8％で成長する見通しです。

世界の乱用薬物検査市場は、薬物乱用の発生率の上昇、厳しい業界規制、ヘルスケアや職場における薬物検査の重要性に対する意識の高まりといった要因に後押しされ、力強い成長を遂げています。国連薬物犯罪事務所（United Nations Office on Drugs and Crime）は、違法薬物の年間使用率が5.3％という驚くべき数字を公表しており、これは全世界で2億5,500万人の使用者に相当し、効果的な検査ソリューションの必要性を高めています。薬物乱用への認識とコンプライアンスを推進する政府のイニシアティブは、厳格な規制とともに、市場の需要をさらに高めています。しかし、微量物質の検出の限界や、娯楽用薬物の合法化法の進展の影響といった課題が、進展の妨げになる可能性があります。とはいえ、免疫学的検定や分子診断学などの検査技術の進歩や、経口液検査への傾倒の高まりは、この分野に大きな成長機会をもたらしています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• ケーススタディ

乱用薬物検査市場規模：製品タイプ別

• 市場概要
• アナライザー
  • 免疫測定分析装置
  • クロマトグラフィー装置
  • 呼気分析装置
• 迅速検査装置
  • 尿検査装置
  • 口腔液検査装置
• 消耗品
  • 体液採取装置
  • その他

乱用薬物検査市場規模：サンプルタイプ別

• 市場概要
• 唾液
• 呼吸
• 尿
• 血
• 毛髪と汗

乱用薬物検査市場規模：用途別

• 市場概要
• 健康診断
• 疼痛管理のモニタリング
• 科学捜査と法的情報
• 雇用薬物検査
• スポーツと陸上競技の検査

乱用薬物検査市場規模：エンドユーザー別

• 市場概要
• 病院
• 診断研究所
• 現地検査
• 法医学研究所

乱用薬物検査市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Abbott Laboratories（US）
• Thermo Fisher Scientific Inc.（US）
• Siemens Healthineers AG（Germany）
• F. Hoffmann-La Roche Ltd（Switzerland）
• Quest Diagnostics Incorporated（US）
• Bio-Rad Laboratories, Inc.（US）
• Dragerwerk AG & Co. KGaA（Germany）
• Biomerieux SA（France）
• Shimadzu Corporation（Japan）
• Randox Laboratories Ltd.（United Kingdom）
• Psychemedics Corporation（US）
• Sonic Healthcare（Australia）
• Merck KGaA（Germany）
• LabCorp（US）
• MP Biomedicals LLC（US）
• Omega Laboratories, Inc.（US）
• Express Diagnostics International Inc.（US）
• Sciteck, Inc.（US）

結論と提言

Global Drug of Abuse Testing Market size was valued at USD 3.8 billion in 2023 and is poised to grow from USD 4.02 billion in 2024 to USD 6.31 billion by 2032, growing at a CAGR of 5.8% during the forecast period (2025-2032).

The global drug of abuse testing market is witnessing robust growth, fueled by factors such as the rising incidence of substance abuse, stringent industry regulations, and heightened awareness of drug testing's significance in healthcare and workplaces. The United Nations Office on Drugs and Crime highlights an alarming 5.3% annual prevalence of illicit drug use, equating to 255 million users globally, intensifying the need for effective testing solutions. Government initiatives promoting drug abuse awareness and compliance, alongside strict regulations, further bolster market demand. However, challenges such as limitations in detecting trace substances and the impact of evolving legalization laws for recreational drugs may hinder progress. Nevertheless, advancements in testing technologies, including immunoassays and molecular diagnostics, as well as the growing inclination towards oral fluid testing, present substantial growth opportunities in this sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Drug Of Abuse Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Drug Of Abuse Testing Market Segments Analysis

Global Drug of Abuse Testing Market is segmented by Product Type, Sample Type, Testing Type, End-user and region. Based on Product Type, the market is segmented into Analyzers, Rapid Testing Devices and Consumables. Based on Sample Type, the market is segmented into Saliva, Breath, Urine, Blood and Hair & Sweat. Based on Application, the market is segmented into Medical Screening, Monitoring Pain Management, Forensic & Legal Information, Employment Drug Testing, Sports & Athletics Testing. Based on End-user, the market is segmented into Hospitals, Diagnostics Laboratories, On-the-spot Testing and Forensic Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Drug Of Abuse Testing Market

The Global Drug of Abuse (DoA) Testing market is poised for significant growth, driven by an increase in the production, consumption, and trafficking of both new and illicit drugs. The World Drug Report 2017 from the United Nations Office on Drugs and Crime highlighted a 5.3% prevalence rate of illicit drug use, translating to around 255 million users by 2015. This alarming statistic emphasizes the pressing need for effective DoA testing solutions, propelling market demand. Furthermore, government initiatives aimed at spreading awareness about drug abuse and ensuring compliance with testing protocols will enhance market expansion, along with the rising preference for testing products that provide superior specificity and sensitivity for detecting designer drugs.

Restraints in the Global Drug Of Abuse Testing Market

The Global Drug of Abuse (DOA) Testing market may encounter several obstacles that could hinder its growth. One significant challenge is the current testing products' inability to effectively detect trace amounts of certain drugs. Moreover, the ongoing changes in legislation aimed at legalizing recreational or illicit substances are anticipated to further complicate market dynamics during the 2023-2030 forecast period. The associated report on the DOA testing market offers extensive insights into recent advancements, trade regulations, production analysis, value chain enhancements, and the influence of local market participants. Additionally, it highlights emerging opportunities, regulatory shifts, market sizes, product innovations, and geographic expansions, providing a comprehensive overview for stakeholders. For in-depth insights, Data Bridge Market Research can provide tailored assistance to navigate these challenges and capitalize on growth opportunities.

Market Trends of the Global Drug Of Abuse Testing Market

The Global Drug of Abuse Testing market is witnessing a significant shift towards point-of-care testing, a trend fueled by an increasing demand for rapid, on-site results that cater to diverse healthcare settings, including remote and decentralized locations. This innovation enhances accessibility for healthcare providers, improves patient management, and addresses the urgent need for timely decision-making in substance abuse cases. The rise of point-of-care testing is further supported by advancements in technology and diagnostic tools, aligning with the broader healthcare movement towards more patient-centered approaches. As a result, this trend is reshaping service delivery and expanding market opportunities in the drug testing sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies

Global Drug of Abuse Testing Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Analyzers
  • Immunoassays Analyzers
  • Chromatographic Devices
  • Breath Analyzers
• Rapid Testing Devices
  • Urine Testing Devices
  • Oral Fluid Testing Devices
• Consumables
  • Fluid Collection Devices
  • Others

Global Drug of Abuse Testing Market Size by Sample Type & CAGR (2025-2032)

• Market Overview
• Saliva
• Breath
• Urine
• Blood
• Hair & Sweat

Global Drug of Abuse Testing Market Size by Application & CAGR (2025-2032)

• Market Overview
• Medical Screening
• Monitoring Pain Management
• Forensic & Legal Information
• Employment Drug Testing
• Sports & Athletics Testing

Global Drug of Abuse Testing Market Size by End-user & CAGR (2025-2032)

• Market Overview
• Hospitals
• Diagnostics Laboratories
• On-the-spot Testing
• Forensic Laboratories

Global Drug of Abuse Testing Market Size & CAGR (2025-2032)

• North America (Product Type, Sample Type, Application, End-user)
  • US
  • Canada
• Europe (Product Type, Sample Type, Application, End-user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Sample Type, Application, End-user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Sample Type, Application, End-user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Sample Type, Application, End-user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quest Diagnostics Incorporated (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dragerwerk AG & Co. KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shimadzu Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories Ltd. (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Psychemedics Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sonic Healthcare (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LabCorp (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MP Biomedicals LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Omega Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Express Diagnostics International Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sciteck, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations